SCHEMBL11367407

SCHEMBL11367407

c1c2c3c(c4c1C(=C1c5cc6c7c(c5Oc5c1cc1c8c5CCCN8CCC1)CCCN7CCC6)c1cc5c6c(c1O4)CCCN6CCC5)CCCN3CCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 9/20 0.44
▸ MEN1 O00255 8/20 0.44
▸ USP2 O75604 7/20 0.44
▸ ALDH1A1 P00352 6/20 0.44
▸ GAA P10253 5/20 0.44
▸ KDM4E B2RXH2 5/20 0.44
▸ MAPT P10636 5/20 0.44
▸ LMNA P02545 5/20 0.44
▸ TDP1 Q9NUW8 4/20 0.44
▸ HSD17B10 Q99714 4/20 0.44
▸ ALOX15 P16050 4/20 0.44
▸ RECQL P46063 3/20 0.44
▸ HPGD P15428 3/20 0.44
▸ POLB P06746 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ PABPC1 P11940 1/20 0.44
▸ NR4A1 P22736 1/20 0.44
▸ APEX1 P27695 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ TLR9 Q9NR96 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705820 0.81 KMT2A (0.46) KMT2AMEN1USP2ALDH1A1GAA
SCHEMBL14423385 0.80 KMT2A (0.42) KMT2AMEN1USP2ALDH1A1GAA
SCHEMBL23702512 0.79 KMT2A (0.43) KMT2AMEN1USP2ALDH1A1GAA
SCHEMBL15187872 0.77 KMT2A (0.38) KMT2AMEN1USP2ALDH1A1GAA
SCHEMBL15932527 0.76 KMT2A (0.42) KMT2AMEN1USP2ALDH1A1GAA
SCHEMBL10017851 0.76 — —
SCHEMBL9915839 0.74 PTGS1 (0.41) KMT2AMEN1USP2ALDH1A1GAA
SCHEMBL12879438 0.74 KMT2A (0.36) KMT2AMEN1USP2ALDH1A1GAA
SCHEMBL14413591 0.74 KMT2A (0.42) KMT2AMEN1USP2ALDH1A1GAA
SCHEMBL14325927 0.74 KMT2A (0.43) KMT2AMEN1USP2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8221903-B2 Materials for N-type doping of the electron transporting layers in organic electronic devices OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2012-07-17 — — US disclosed
US-8221903-B2 Materials for N-type doping of the electron transporting layers in organic electronic devices OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2012-07-17 — — US disclosed
EP-2267812-A1 Novel materials for n-type doping of the electron transporting layers in organic electronic devices, their use and organic electronic devices OSRAM Opto Semiconductors GmbH (DE) 2010-12-29 — — EP disclosed
US-20080297035-A1 Novel Materials for N-Type Doping of the Electron Transporting Layers in Organic Electronic Devices DOLYA HOLDCO 5 LIMITED (IE) 2008-12-04 — — US disclosed
US-20080297035-A1 Novel Materials for N-Type Doping of the Electron Transporting Layers in Organic Electronic Devices DOLYA HOLDCO 5 LIMITED (IE) 2008-12-04 — — US disclosed
WO-2007028738-A1 NOVEL MATERIALS FOR N-TYPE DOPING OF THE ELECTRON TRANSPORTING LAYERS IN ORGANIC ELECTRONIC DEVICES SIEMENS AKTIENGESELLSCHAFT (DE) 2007-03-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080297035-A1 Novel Materials for N-Type Doping of the Electron Transporting Layers in Organic Electronic Devices SLCO4C1, SLCO1A2, SLCO2A1 KMT2A 2801/4885MEN1 2777/4885USP2 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback